MedPath

Resposal-I

Brand Name: Resposal-I

Generic Name: Salbutamol (as sulfate) + Ipratropium Bromide

Active
Registration Number

DRP-4672

Dosage Form

Solution for Nebulization

Issuance Date

February 2, 2023

Expiry Date

February 2, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2.5 mg/500 mcg per 2.5 mL
Packaging2.5 mL net content in 5 mL LDPE nebule (Box of 30 nebules in strips of 5's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial (Variation)
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Salbutamol (as sulfate)Active
Ipratropium BromideActive
Monograph: Ipratropium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform